- Home
- DOMO vs TERN Comparison
DOMO vs TERN Comparison
Compare DOMO & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOMO
- TERN
- Stock Information
- Founded
- DOMO 2010
- TERN 2017
- Country
- DOMO United States
- TERN United States
- Employees
- DOMO N/A
- TERN N/A
- Industry
- DOMO Computer Software: Prepackaged Software
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- DOMO Technology
- TERN Health Care
- Exchange
- DOMO Nasdaq
- TERN Nasdaq
- Market Cap
- DOMO 562.5M
- TERN 634.5M
- IPO Year
- DOMO 2018
- TERN 2021
- Fundamental
- Price
- DOMO $15.02
- TERN $7.16
- Analyst Decision
- DOMO Buy
- TERN Buy
- Analyst Count
- DOMO 8
- TERN 6
- Target Price
- DOMO $15.13
- TERN $13.99
- AVG Volume (30 Days)
- DOMO 819.6K
- TERN 1.2M
- Earning Date
- DOMO 08-27-2025
- TERN 08-05-2025
- Dividend Yield
- DOMO N/A
- TERN N/A
- EPS Growth
- DOMO N/A
- TERN N/A
- EPS
- DOMO N/A
- TERN N/A
- Revenue
- DOMO $318,363,000.00
- TERN N/A
- Revenue This Year
- DOMO $1.78
- TERN N/A
- Revenue Next Year
- DOMO $2.66
- TERN N/A
- P/E Ratio
- DOMO N/A
- TERN N/A
- Revenue Growth
- DOMO N/A
- TERN N/A
- 52 Week Low
- DOMO $6.01
- TERN $1.87
- 52 Week High
- DOMO $17.88
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- DOMO 51.01
- TERN 58.24
- Support Level
- DOMO $13.85
- TERN $6.78
- Resistance Level
- DOMO $17.88
- TERN $7.78
- Average True Range (ATR)
- DOMO 0.89
- TERN 0.48
- MACD
- DOMO -0.01
- TERN -0.03
- Stochastic Oscillator
- DOMO 37.31
- TERN 59.63
About DOMO Domo Inc. Class B
Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.